P-Monofer-IBD-01
Research type
Research Study
Full title
A phase III, randomized, comparative, open-label study of intravenous iron oligosaccharide (Monofer®) administered by infusions or repeated bolus injections in comparison with oral iron sulphate in inflammatory bowel disease subjects with iron deficiency anaemia
IRAS ID
24807
Sponsor organisation
Pharmacosmos A/S
Eudract number
2009-012544-16
ISRCTN Number
n/a
Clinicaltrials.gov Identifier
n/a
Research summary
N/A
REC name
East Midlands - Leicester South Research Ethics Committee
REC reference
09/H0402/102
Date of REC Opinion
31 Dec 2009
REC opinion
Further Information Favourable Opinion